Willie Moss

Willie Moss serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and diagnostic capabilities. Responsible for managing complex contracts that enable laboratory diagnostics, biomedical research, and data-driven surveillance systems, Moss facilitates the acquisition of high-precision analytical instruments, in-vitro diagnostic substances, and specialized technical services essential to rapid response operations. Their work directly supports CDC’s ability to detect, monitor, and mitigate infectious disease threats through timely and compliant procurement processes aligned with federal health security priorities. Moss maintains consistent working relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations that deliver advanced laboratory technologies, clinical diagnostics, and public health data solutions. These collaborations are characterized by long-term, performance-based contract structures that emphasize technical reliability, regulatory compliance, and scalability across national and global health response networks. The procurement approach prioritizes mission-critical delivery over transactional sourcing, fostering deep vendor engagement in complex, high-stakes health security initiatives. Moss’s contracting activity shows no reliance on socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic focus on technical capability and operational readiness over socioeconomic criteria, aligning with CDC’s urgent need for proven, scalable solutions in time-sensitive public health emergencies. While small business participation is not formally prioritized in award distribution, the procurement framework remains transparent and accessible to all qualified vendors meeting stringent technical and compliance standards. The primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 325413 (in-vitro diagnostic substance manufacturing), with significant activity in professional scientific services under 541990. Moss specializes in acquiring next-generation sequencing platforms, automated diagnostic systems, biosafety equipment, and data analytics tools that underpin CDC’s surveillance infrastructure and laboratory network modernization efforts.